trientine has been researched along with Epithelial Neoplasms in 1 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, S | 1 |
Naing, A | 1 |
Fu, C | 1 |
Kuo, MT | 1 |
Kurzrock, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase I Study of Trientine and Carboplatin in Patients With Advanced Malignancies[NCT01178112] | Phase 1 | 56 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for trientine and Epithelial Neoplasms
Article | Year |
---|---|
Overcoming platinum resistance through the use of a copper-lowering agent.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cation Transport Proteins; | 2012 |